EVE Health Group (EVE) Stock Price, News & Analysis
S&P 500   5,146.29 (-1.01%)
DOW   38,109.02 (-0.91%)
QQQ   439.36 (-1.35%)
AAPL   176.09 (+0.60%)
MSFT   421.40 (-1.53%)
META   513.96 (-1.76%)
GOOGL   157.77 (-1.03%)
AMZN   186.56 (-1.32%)
TSLA   171.84 (-1.58%)
NVDA   885.43 (-2.29%)
AMD   163.63 (-4.03%)
NIO   4.13 (-7.40%)
BABA   72.44 (-3.22%)
T   16.44 (+0.12%)
F   12.73 (-2.38%)
MU   123.37 (-3.25%)
GE   154.44 (-1.88%)
CGC   8.05 (-1.23%)
DIS   114.19 (-2.53%)
AMC   2.70 (-3.57%)
PFE   26.14 (-0.76%)
PYPL   65.40 (-0.61%)
XOM   123.30 (+1.24%)
S&P 500   5,146.29 (-1.01%)
DOW   38,109.02 (-0.91%)
QQQ   439.36 (-1.35%)
AAPL   176.09 (+0.60%)
MSFT   421.40 (-1.53%)
META   513.96 (-1.76%)
GOOGL   157.77 (-1.03%)
AMZN   186.56 (-1.32%)
TSLA   171.84 (-1.58%)
NVDA   885.43 (-2.29%)
AMD   163.63 (-4.03%)
NIO   4.13 (-7.40%)
BABA   72.44 (-3.22%)
T   16.44 (+0.12%)
F   12.73 (-2.38%)
MU   123.37 (-3.25%)
GE   154.44 (-1.88%)
CGC   8.05 (-1.23%)
DIS   114.19 (-2.53%)
AMC   2.70 (-3.57%)
PFE   26.14 (-0.76%)
PYPL   65.40 (-0.61%)
XOM   123.30 (+1.24%)
S&P 500   5,146.29 (-1.01%)
DOW   38,109.02 (-0.91%)
QQQ   439.36 (-1.35%)
AAPL   176.09 (+0.60%)
MSFT   421.40 (-1.53%)
META   513.96 (-1.76%)
GOOGL   157.77 (-1.03%)
AMZN   186.56 (-1.32%)
TSLA   171.84 (-1.58%)
NVDA   885.43 (-2.29%)
AMD   163.63 (-4.03%)
NIO   4.13 (-7.40%)
BABA   72.44 (-3.22%)
T   16.44 (+0.12%)
F   12.73 (-2.38%)
MU   123.37 (-3.25%)
GE   154.44 (-1.88%)
CGC   8.05 (-1.23%)
DIS   114.19 (-2.53%)
AMC   2.70 (-3.57%)
PFE   26.14 (-0.76%)
PYPL   65.40 (-0.61%)
XOM   123.30 (+1.24%)
S&P 500   5,146.29 (-1.01%)
DOW   38,109.02 (-0.91%)
QQQ   439.36 (-1.35%)
AAPL   176.09 (+0.60%)
MSFT   421.40 (-1.53%)
META   513.96 (-1.76%)
GOOGL   157.77 (-1.03%)
AMZN   186.56 (-1.32%)
TSLA   171.84 (-1.58%)
NVDA   885.43 (-2.29%)
AMD   163.63 (-4.03%)
NIO   4.13 (-7.40%)
BABA   72.44 (-3.22%)
T   16.44 (+0.12%)
F   12.73 (-2.38%)
MU   123.37 (-3.25%)
GE   154.44 (-1.88%)
CGC   8.05 (-1.23%)
DIS   114.19 (-2.53%)
AMC   2.70 (-3.57%)
PFE   26.14 (-0.76%)
PYPL   65.40 (-0.61%)
XOM   123.30 (+1.24%)
ASX:EVE

EVE Health Group (EVE) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.21 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
8.15%
Price Target
N/A
EVE stock logo

About EVE Health Group Stock (ASX:EVE)

Eve Health Group Limited, together with its subsidiaries, engages in the production and distribution of nutrition, health, and wellness products in Australia, New Zealand, the Asia Pacific, and North America. It provides organic tea tree oils; and distributes botanical oils, as well as supplies essential oils, hydrosols, extracts, carrier oils, and seed oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. In addition, it offers medical nutrition solutions for chronic and lifestyle diseases, including Gluco Smooth for type 2 diabetes that reduces the post-meal blood sugar levels; and dietary interventions. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

EVE Stock News Headlines

Analysts Predict Price Tag for Gold to TRIPLE
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
Remarkable Women 2024: Eve Molzhon
Analysts Predict Price Tag for Gold to TRIPLE
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
See More Headlines
Receive EVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EVE Health Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Net Income
$-1,990,000.00
Net Margins
-157.88%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.28 million

Miscellaneous

Outstanding Shares
5,270,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.09
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Gregory William Fry (Age 58)
    MD & CEO
    Comp: $211.2k
  • Mr. Benedict James Rohr
    Chief Operating Officer
  • Mr. Steven Luke Jackson BEc
    C.P.A., CPA, CFO & Company Secretary
  • Ms. Stephanie Yip
    Marketing Director

This page (ASX:EVE) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners